Keywords
Low Density Lipoprotein
Cardiac Stroke
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To gather laboratory data on triglycerides (TG) and low-density lipoproteins (LDL) and compare them to the risk of developing cardiac vascular accidents (CVA). Methods: Observational, cross-sectional study, with a quantitative analytical approach, based on the analysis of LDL and TG levels of patients at LAC - PUC Goiás from October 2023 to November 2023. Data were tabulated using Microsoft Office Excel 365 and analyzed with the Statistical Package for Social Science. Results: 1025 patients were analyzed, regarding sex and the classification of isolated hypercholesterolemia, mixed hyperlipidemia and isolated hypertriglyceridemia of the sample, the p value was 0.725, indicating the absence of a significant relationship. In relation to age groups, a value of p<0.001 was obtained, showing a significant relationship. Post hoc analysis revealed a higher prevalence of isolated hypertriglyceridemia in the age group of 50 to 59 years (23.8%). Conclusion: Greater attention is needed to patients who are entering the age range of 50 to 59 years, with the aim of screening, diagnosing and offering treatment that acts to prevent possible strokes.
References
DOS SANTOS EB e BIANCO HT. Atualizações em doença cardíaca isquêmica aguda e crônica. Revista da Sociedade Brasileira de Clínica Médica, 2018; 16(1): 52-58.
FALUDI AA, et al. Atualização da diretriz brasileira de dislipidemias e prevenção da aterosclerose – 2017. Arquivos Brasileiros de Cardiologia, 2017; 109(2 Supl.1): 1-2.
FARNIER M, et al. Triglycerides and Risk of Atherosclerotic Cardiovascular Disease: An Update. Archives of Cardiovascular Diseases, 2021; 114(2): 132-139.
FERENCE BA, et al. Association of Triglyceride-Lowering LPL Variants and LDL-C-Lowering LDLR Variants with Risk of Coronary Heart Disease. JAMA, 2019; 321: 364-373.
GUEDES RF, et al. Análise do perfil lipídico e dos fatores de risco associados a doenças cardiovasculares em acadêmicos da área da saúde. HU Revista, 2016; 42(2).
JUN M, et al. Effects of Fibrates on Cardiovascular Outcomes: A Systematic Review and Meta-Analysis. Lancet, 2010; 375: 1875-1884.
MACH F, et al. 2019 ESC/EAS Guidelines for the Management of Dyslipidaemias: Lipid Modification to Reduce Cardiovascular Risk. European Heart Journal, 2020; 41: 111-188.
OLIVEIRA GMM, et al. Cardiovascular Statistics - Brazil 2020. Arquivos Brasileiros de Cardiologia, 2020; 115: 308-439.
OLIVEIRA GMM, et al. Atualização da diretriz de prevenção cardiovascular da Sociedade Brasileira de Cardiologia - 2019. Arquivos Brasileiros de Cardiologia, 2019; 113(4): 795-796.
PIEGAS LS, et al. V Diretriz da Sociedade Brasileira de Cardiologia sobre tratamento do infarto agudo do miocárdio com supradesnível do segmento ST. Arquivos Brasileiros de Cardiologia, 2015; 105(2): 2-3.
PORTZ EH, et al. Manejo da dislipidemia. Management of dyslipidemia. LILACS, 2018; 39(2).
SA ACMGN, et al. Fatores associados ao LDL-Colesterol aumentado na população adulta brasileira: Pesquisa Nacional de Saúde. Ciência & Saúde Coletiva, 2021; 26: 541-553.
SHI S, et al. Yanyu Decoction for Aged Patients with Stable Coronary Artery Disease: A Systematic Review and Meta-Analysis. Evidence-Based Complementary and Alternative Medicine, 2021; 2021: 6615035.
SI S, et al. Exploring the Causal Roles of Circulating Remnant Lipid Profile on Cardiovascular and Cerebrovascular Diseases: Mendelian Randomization Study. Journal of Epidemiology, 2022; 32(5): 205-214.
TOHT PP, et al. Risk of Cardiovascular Events in Patients with Hypertriglyceridaemia: A Review of Real-world Evidence. Diabetes, Obesity and Metabolism, 2020; 22(3): 279-289.
VALENÇA SO, et al. Prevalence of dyslipidemias and food consumption: a population-based study. Ciência & Saúde Coletiva, 2021; 26(11): 5765-5776.
WANG N, et al. Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327,037 participants. The Lancet Diabetes & Endocrinology, 2020; 8(1): 36-49.
ZHANG S, et al. Ezetimibe for the prevention of cardiovascular disease and all-cause mortality events. Cochrane Database of Systematic Reviews, 2018; 11.
ZHUANG Z, et al. Association of physical activity, sedentary behaviours and sleep duration with cardiovascular diseases and lipid profiles: a Mendelian randomization analysis. Lipids in Health and Disease, 2020; 19(1): 86.
UCANI M, et al. Risk Factors for Premature Myocardial Infarction: A Systematic Review and Meta-analysis of 77 Studies. Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 2021; 5(4): 783-794.